5/10
08:38 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
5/9
09:40 am
amlx
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
5/9
07:06 am
amlx
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/9
07:00 am
amlx
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
Low
Report
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
5/8
09:31 am
amlx
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference [Yahoo! Finance]
5/8
09:00 am
amlx
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
Medium
Report
Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference
5/2
09:31 am
amlx
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 [Yahoo! Finance]
5/2
09:00 am
amlx
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
Low
Report
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
4/25
10:52 pm
amlx
Lifshitz Law PLLC Announces Investigations of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), Cassava Sciences, Inc. (NASDAQ:SAVA), GrafTech International Ltd. (NYSE:EAF), and Mobileye Global Inc. (NASDAQ:MBLY)
Low
Report
Lifshitz Law PLLC Announces Investigations of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), Cassava Sciences, Inc. (NASDAQ:SAVA), GrafTech International Ltd. (NYSE:EAF), and Mobileye Global Inc. (NASDAQ:MBLY)
4/15
11:21 am
amlx
Investigation Alert Amylyx, Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP
Low
Report
Investigation Alert Amylyx, Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP
4/12
11:02 am
amlx
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals [Yahoo! Finance]
Medium
Report
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals [Yahoo! Finance]
4/11
08:06 am
amlx
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its price target lowered by analysts at Robert W. Baird from $4.00 to $3.00. They now have a "neutral" rating on the stock.
Medium
Report
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) had its price target lowered by analysts at Robert W. Baird from $4.00 to $3.00. They now have a "neutral" rating on the stock.
4/10
03:29 pm
amlx
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder [Yahoo! Finance]
4/10
09:27 am
amlx
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome [Yahoo! Finance]
4/10
09:00 am
amlx
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
High
Report
Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
4/9
12:45 pm
amlx
April 9, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - AMLX
Neutral
Report
April 9, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - AMLX
4/9
11:00 am
amlx
Investors in Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLX
Neutral
Report
Investors in Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLX
4/9
10:32 am
amlx
AMLX DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Alerts Amylyx Pharmaceuticals (AMLX) Investors to Today’s Lead Plaintiff Deadline in Securities Fraud Class Action
Low
Report
AMLX DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Alerts Amylyx Pharmaceuticals (AMLX) Investors to Today’s Lead Plaintiff Deadline in Securities Fraud Class Action
4/9
07:30 am
amlx
Levi & Korsinsky Notifies Shareholders of Amylyx Pharmaceuticals, Inc.(AMLX) of a Class Action Lawsuit and an Upcoming Deadline
Low
Report
Levi & Korsinsky Notifies Shareholders of Amylyx Pharmaceuticals, Inc.(AMLX) of a Class Action Lawsuit and an Upcoming Deadline
4/9
07:00 am
amlx
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Low
Report
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
4/9
05:45 am
amlx
The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX
Low
Report
The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX
4/9
05:00 am
amlx
Lost Money on Amylyx Pharmaceuticals, Inc. (AMLX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Low
Report
Lost Money on Amylyx Pharmaceuticals, Inc. (AMLX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
4/9
04:00 am
amlx
FINAL AMLX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Amylyx Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!
Low
Report
FINAL AMLX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Amylyx Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!
4/8
07:00 pm
amlx
Investors in Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights – AMLX
Low
Report
Investors in Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights – AMLX
4/8
06:45 pm
amlx
AMYLYX PHARMACEUTICALS 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX
Low
Report
AMYLYX PHARMACEUTICALS 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX